Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
11.33
-0.05 (-0.44%)
At close: Jul 18, 2025, 4:00 PM
11.56
+0.23 (2.03%)
After-hours: Jul 18, 2025, 5:20 PM EDT
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.80 billion as of July 18, 2025. Its market cap has increased by 74.96% in one year.
Market Cap
1.80B
Enterprise Value
1.53B
1-Year Change
74.96%
Ranking
Category
Stock Price
$11.33
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.80B, an increase of 567.23%. That is a compound annual growth rate of 18.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 17, 2025 | 1.81B | 35.02% |
Dec 31, 2024 | 1.34B | 279.05% |
Dec 29, 2023 | 354.20M | 63.68% |
Dec 30, 2022 | 216.40M | -59.48% |
Dec 31, 2021 | 534.00M | -63.87% |
Dec 31, 2020 | 1.48B | 678.20% |
Dec 31, 2019 | 189.90M | 16.08% |
Dec 31, 2018 | 163.60M | 24.89% |
Dec 29, 2017 | 131.00M | -37.08% |
Dec 30, 2016 | 208.20M | -10.18% |
Dec 31, 2015 | 231.80M | -53.78% |
Dec 31, 2014 | 501.50M | 85.40% |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 709.03B |
Johnson & Johnson | 396.47B |
AbbVie | 336.64B |
Novo Nordisk | 301.36B |
UnitedHealth Group | 265.33B |
Novartis AG | 233.75B |
Abbott Laboratories | 229.21B |
AstraZeneca | 217.77B |